spacer
home > ebr > winter 2009 > streamlining processes
PUBLICATIONS
European Biopharmaceutical Review

Streamlining Processes

Procurement officers, lab managers and CFOs at pharmaceutical and biopharmaceutical companies are under tremendous pressure to improve internal processes, outsource internal functions and focus on suppliers’ costs. They have traditionally relied on original equipment manufacturers (OEMs) to maintain their vast and diverse range of laboratory equipment and inventories. This is fine if there are only a small number of assets, but the majority of biopharmaceutical companies have hundreds of assets, each requiring individual maintenance contracts.

Furthermore, there are a number of disadvantages to this model, including the administrative burden on employees (and hence the detraction from normal work), and the time it takes to manage vast inventories, which can divert resources away from core scientific projects.

One way to improve asset management efficiency and drive down costs is to use an external multi-vendor asset management service to maintain all laboratory equipment and inventory. Such third-party service providers can offer a wide range of services, including:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Bob Moore is the North American Service Sales Director for GE Healthcare’s Life Sciences business. Bob started his career with GE in 1986. His vast service experience with GE Healthcare began as a field engineer, and he has spent the last few years in developing and marketing GE’s service offerings and business solutions for the life science markets. Bob holds a BS EET degree from DeVry Technical Institute in Chicago, IL. Bob has also received extensive leadership training at the John F. Welch Leadership Training Center in Crotonville, NY.
spacer
Bob Moore
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

CytoSMART Technologies Introduces Machine-Learning Algorithm for Organoid Analysis on the CytoSMART Omni Systems

9 June 2022, Eindhoven, The Netherlands – Life Science Newswire – CytoSMART Technologies, an Axion Bio company, today announced the launch of a new Organoid Analysis Module for use with its flagship CytoSMART Omni live-cell imaging product line. The innovative software module, which incorporates next-generation machine learning capabilities, is designed to meet growing scientific demand from researchers and drug developers using complex three-dimensional (3D) in vitro models such as organoids, spheroids, and tumoroids to study disease mechanisms and identify therapeutic targets in the fields of neurology, gastroenterology, oncology and more.
More info >>

White Papers

galenIQ - The smart excipient

BENEO GmbH

galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement